CHENGDU, China, May 29, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, results from the pivotal Phase II study of the Company's next-generation selective RET inhibitor, lunbotinib fumarate (A400/EP0031, 宁泰莱®[1]), in advanced rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC) were presented as an oral report by Professor Qing Zhou from Guangdong Provincial People's Hospital (Abstract #8505, Lung Cancer—Metastatic Non-Small Cell). Based on these results, a New Drug Application (NDA) for lunbotinib fumarate for the treatment of adult patients with locally advanced or metastatic RET fusion-positive NSCLC has been accepted by the National Medical Products Administration (NMPA) of China.
kAm%96 DEF5J 6?C@==65 f` A2E:6?ED H9@ 925 AC6G:@FD=J C646:G65 A=2E:?F>\32D65 496>@E96C2AJ 2?5 :>>F?@E96C2AJ WAC6\EC62E65 A2E:6?EDX 2?5 ha A2E:6?ED H9@ 925 ?@E C646:G65 AC:@C DJDE6>:4 E96C2AJ WEC62E>6?E\?2ïG6 A2E:6?EDX] pD @7 E96 52E2 4FE@77 52E6 @7 ~4E@36C ah[ a_ad[ E96 >65:2? 7@==@H\FA H2D aa]e >@?E9D 2?5 a_]f >@?E9D[ C6DA64E:G6=J]k^Am
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56Cefh`QmkAmk2 9C67lQ9EEADi^^>>2]AC?6HDH:C6]4@>^>65:2^ahh`afb^:>286a]9E>=Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmk^2mk^Amk^5:Gm
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56CgcdgQmkAmk2 9C67lQ9EEADi^^>>2]AC?6HDH:C6]4@>^>65:2^ahh`afd^:>286b]9E>=Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmk^2mk^Amk^5:Gm
kAm%96 4@?7:C>65 @3;64E:G6 C6DA@?D6 C2E6 W~##X 2DD6DD65 3J x?56A6?56?E #6G:6H r@>>:EE66 Wx#rX H2D g`]bT WhdT rxi f`]g–gg]fX :? EC62E>6?E\?2ïG6 A2E:6?ED 2?5 gf]`T WhdT rxi ff]_–hb]hX :? AC6\EC62E65 A2E:6?ED]k^Am
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56CgbfbQmkAmk2 9C67lQ9EEADi^^>>2]AC?6HDH:C6]4@>^>65:2^ahh`afe^:>286c]9E>=Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmk^2mk^Amk^5:Gm
kAmx? EC62E>6?E\?2ïG6 A2E:6?ED[ >65:2? 5FC2E:@? @7 C6DA@?D6 W>s~#X 2?5 >65:2? AC@8C6DD:@?\7C66 DFCG:G2= W>!u$X H6C6 ?@E C624965] x? AC6\EC62E65 A2E:6?ED[ >s~# H2D ad]f >@?E9D[ 2?5 >!u$ H2D af]d >@?E9D]k^Am
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56Ce`fhQmkAmk2 9C67lQ9EEADi^^>>2]AC?6HDH:C6]4@>^>65:2^ahh`af`^:>286d]9E>=Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmk^2mk^Amk^5:Gm
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56Cf_abQmkAmk2 9C67lQ9EEADi^^>>2]AC?6HDH:C6]4@>^>65:2^ahh`afa^:>286e]9E>=Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmk^2mk^Amk^5:Gm
kAmp>@?8 c_ A2E:6?ED H:E9 46?EC2= ?6CG@FD DJDE6> Wr}$X >6E2DE2D6D 2E 32D6=:?6 W2DD6DD65 3J x#r A6C C6DA@?D6 2DD6DD>6?E :? ?6FC@\@?4@=@8J 3C2:? >6E2DE2D6D W#p}~\q|X 4C:E6C:2X[ E96 :?EC24C2?:2= 4@>A=6E6 C6DA@?D6 Wr#X C2E6 H2D b_T[ 2?5 E96 5:D62D6 4@?EC@= C2E6 Wsr#X H2D ha]dT WhdT rxi fh]e–hg]cX]k^Am
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56CcfcbQmkAmk2 9C67lQ9EEADi^^>>2]AC?6HDH:C6]4@>^>65:2^ahh`afc^:>286f]9E>=Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmk^2mk^Amk^5:Gm
kAm{F?3@E:?:3 7F>2C2E6 H2D H6== E@=6C2E65[ H:E9 EC62E>6?E\C6=2E65 25G6CD6 6G6?ED W%#ptDX 36:?8 AC65@>:?2?E=J vC256 `–a] %96 C2E6 @7 A6C>2?6?E 5:D4@?E:?F2E:@? 5F6 E@ %#ptD H2D `]aT[ 2?5 ?@ EC62E>6?E\C6=2E65 562E9D H6C6 C6A@CE65]k^Am
kAm%96 DEF5J D9@HD E92E =F?3@E:?:3 7F>2C2E6 56>@?DEC2E65 C@3FDE 2?5 5FC23=6 4=:?:42= 24E:G:EJ :? #t% 7FD:@?\A@D:E:G6 }$r{r[ C682C5=6DD @7 =:?6 @7 E96C2AJ[ :? 2 =2C86=J A@@C\AC@8?@DE:4 A2E:6?E A@AF=2E:@?] u2G@C23=6 r}$ 677:424J H2D @3D6CG65 :? A2E:6?ED H:E9 >62DFC23=6 32D6=:?6 r}$ >6E2DE2D6D] %96 D276EJ AC@7:=6 H2D >2?28623=6[ H:E9 ?@ F?6IA64E65 D276EJ D:8?2=D]k^Am
kAm!C@76DD@C ":?8 +9@F[ AC:?4:A2= :?G6DE:82E@C 7C@> vF2?85@?8 !C@G:?4:2= !6@A=6VD w@DA:E2=[ D2:5i QuC@> E96 7:CDE AC6D6?E2E:@? @7 !92D6 x 52E2 2E p$r~ a_ab E@ E@52JVD A:G@E2= !92D6 xx C6DF=ED[ H6 92G6 H:E?6DD65 E96 AC@8C6DD:@? @7 =F?3@E:?:3 7F>2C2E6 7C@> 62C=J 6IA=@C2E:@? E@ 2 4@?7:C>2E@CJ DEF5J] %96D6 52E2 D9@H E92E =F?3@E:?:3 7F>2C2E6 56=:G6CD C@3FDE 2?5 5FC23=6 C6DA@?D6D :? 3@E9 EC62E>6?E\?2ïG6 2?5 AC6\EC62E65 A2E:6?ED H:E9 #t% 7FD:@?\A@D:E:G6 }$r{r[ H:E9 A2CE:4F=2C=J C6>2C<23=6 :?EC24C2?:2= 677:424J :? A2E:6?ED H:E9 r}$ >6E2DE2D6D 2E 32D6=:?6] pD 2 ?6IE\86?6C2E:@? D6=64E:G6 #t% :?9:3:E@C[ :E H:== @776C 2? :>A@CE2?E ?6H EC62E>6?E @AE:@? 7@C A2E:6?ED]Qk^Am
k5:GmkE23=6 3@C56ClQ_Q 46==DA24:?8lQ_Q 46==A255:?8lQ`Q 4=2DDlQAC?344QmkECmkE5 4=2DDlQAC?86?aQ 4@=DA2?lQ`Q C@HDA2?lQ`QmkA 4=2DDlQAC?>=cQmkDA2? 4=2DDlQAC?6HD0DA2?Qm,`. %C256 ?2>6 E@ 36 2AAC@G65 3J }|!p]k^DA2?mk^Amk^E5mk^ECmkECmkE5 4=2DDlQAC?86?aQ 4@=DA2?lQ`Q C@HDA2?lQ`Qmk3C ^mk3C ^mk^E5mk^ECmk^E23=6mk^5:Gm
kAmkDEC@?8mkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6Qmp3@FE =F?3@E:?:3 7F>2C2E6 Wpc__^t!__b`[k^DA2?mk^DEC@?8m kDEC@?8mkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6Qm宁泰莱k^DA2?mk^DEC@?8mkDEC@?8mkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6QmkDFAm®k^DFAmk^DA2?mk^DEC@?8mkDEC@?8mkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6QmXk^DA2?mk^DEC@?8mk^Am
kAm{F?3@E:?:3 7F>2C2E6 :D 2 ?@G6=[ ?6IE\86?6C2E:@? D6=64E:G6 #t% :?9:3:E@C 7@C }$r{r[ >65F==2CJ E9JC@:5 42?46C W|%rX 2?5 @E96C D@=:5 EF>@CD H:E9 2 9:89 AC6G2=6?46 @7 #t% 2=E6C2E:@?D] %96 }sp @7 =F?3@E:?:3 7F>2C2E6 92D 366? 2446AE65 7@C C6G:6H 3J E96 }|!p @7 r9:?2 7@C E96 EC62E>6?E @7 25F=E A2E:6?ED H:E9 #t%\7FD:@? A@D:E:G6 =@42==J 25G2?465 @C >6E2DE2E:4 }$r{r] %96 r@>A2?J :D 2=D@ 4@?5F4E:?8 2 !92D6 x3^xx 4=:?:42= DEF5J :? r9:?2 7@C E96 EC62E>6?E @7 #t%\A@D:E:G6 D@=:5 EF>@CD]k^Am
kAmx? |2C49 a_a`[ E96 r@>A2?J 8C2?E65 t==:AD6D !92C>2 {:>:E65[ 2 &]z]\32D65 :?E6C?2E:@?2= @?4@=@8J 5CF8 56G6=@A>6?E 4@>A2?J[ 2? 6I4=FD:G6 =:46?D6 E@ 56G6=@A[ >2?F724EFC6 2?5 4@>>6C4:2=:K6 E9:D 286?E @FED:56 vC62E6C r9:?2 2?5 46CE2:? pD:2? 4@F?EC:6D] x? pAC:= a_ac[ =F?3@E:?:3 7F>2C2E6 H2D 4=62C65 3J E96 u@@5 2?5 sCF8 p5>:?:DEC2E:@? WuspX E@ AC@8C6DD :?E@ 2 !92D6 xx 4=:?:42= EC:2= W}r%_dccb`aeX H9:49 :D 4FCC6?E=J C64CF:E:?8 :? E96 &?:E65 $E2E6D[ &?:E65 z:?85@>[ tFC@A6 2?5 &?:E65 pC23 t>:C2E6D[ H96C6 :E :D 36:?8 6G2=F2E65 2D 2 >@?@E96C2AJ 2?5 :? 4@>3:?2E:@? H:E9 496>@E96C2AJ :? #t% 7FD:@? A@D:E:G6 25G2?465 }$r{r]k^Am
kAmkDEC@?8mkDA2? DEJ=6lQE6IE\564@C2E:@?i F?56C=:?6Qmp3@FE z6=F?\q:@E649k^DA2?mk^DEC@?8mk^Am
kAmz6=F?\q:@E649 Wehh_]wzX :D 2 9@=5:?8 DF3D:5:2CJ @7 z6=F? !92C>246FE:42=[ H9:49 7@4FD6D @? E96 #U2>Ajs[ >2?F724EFC:?8[ 4@>>6C4:2=:K2E:@? 2?5 8=@32= 4@==23@C2E:@? @7 :??@G2E:G6 3:@=@8:42= 5CF8D 2?5 D>2== >@=64F=6 5CF8D] z6=F?\q:@E649 7@4FD6D @? >2;@C 5:D62D6 2C62D DF49 2D D@=:5 EF>@CD[ 2FE@:>>F?6[ 2?5 >6E23@=:4 5:D62D6D[ 2?5 :? 6DE23=:D9:?8 2 8=@32=:K65 5CF8 56G6=@A>6?E 2?5 :?5FDEC:2=:K2E:@? A=2E7@C> E@ 255C6DD E96 F?>6E >65:42= ?665D :? r9:?2 2?5 E96 C6DE @7 H@C=5] z6=F?\q:@E649 :D 4@>>:EE65 E@ 364@>:?8 2 =625:?8 8=@32= 6?E6CAC:D6 :? E96 7:6=5 @7 :??@G2E:G6 5CF8D] pE AC6D6?E[ z6=F?\q:@E649 92D >@C6 E92? b_ @?8@:?8 <6J :??@G2E:G6 5CF8 AC@;64ED[ @7 H9:49 c AC@;64ED H:E9 g :?5:42E:@?D 92G6 366? 2AAC@G65 7@C >2C<6E:?8[ ` AC@;64E :D :? E96 }sp DE286 2?5 >@C6 E92? `_ AC@;64ED 2C6 :? E96 4=:?:42= DE286] z6=F?\q:@E649 92D 6DE23=:D965 @?6 @7 E96 H@C=5VD =625:?8 AC@AC:6E2CJ psr 2?5 ?@G6= sr A=2E7@C>D[ ~AE:sr™[ 2?5 92D a psr AC@;64ED H:E9 d :?5:42E:@?D 2AAC@G65 7@C >2C<6E:?8[ 2?5 >F=E:A=6 psr 2?5 ?@G6= sr 2DD6ED :? 4=:?:42= @C AC64=:?:42= C6D62C49 DE286] u@C >@C6 :?7@C>2E:@?[ A=62D6 G:D:E k2 9C67lQ9EEADi^^6?]<6=F?\3:@E649]4@>^Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm9EEADi^^6?]<6=F?\3:@E649]4@>^k^2m]k^Am
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56C_QmkAmk2 9C67lQ9EEADi^^>>2]AC?6HDH:C6]4@>^>65:2^aed_e`f^=@8@0<6=F?0q:@E6490{@8@]9E>=Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmk^2mk^Amk^5:Gm
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}f`gf_U2>AjD5la_ae\_d\ahQ ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^<6=F?\3:@E649\AC6D6?ED\A:G@E2=\A92D6\::\52E2\7@C\=F?3@E:?:3\7F>2C2E6\2c__6A__b`\:?\C6E\7FD:@?\A@D:E:G6\?D4=4\2E\a_ae\2D4@\b_afgea_a]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^<6=F?\3:@E649\AC6D6?ED\A:G@E2=\A92D6\::\52E2\7@C\=F?3@E:?:3\7F>2C2E6\2c__6A__b`\:?\C6E\7FD:@?\A@D:E:G6\?D4=4\2E\a_ae\2D4@\b_afgea_a]9E>=k^2mk^Am
kAm$~&#rt z6=F?\q:@E649k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}f`gf_U2>Aj%C2?D>:DD:@?0x5la_ae_dahabah!#0}t($0&$!#00000r}f`gf_U2>Ajs2E6x5la_ae_dahQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.